• Als Spam markieren
• Beitrag melden

• 
  Diese Gruppe Alles

• Archiv
• RSS-Feeds

• Kontakt
• Hilfe
• Impressum
• Datenschutz

Multiple chemical sensitivity: study of 52 cases

Note from Ilena Rosenthal:  Unfortunately, the industry / ACSH /
quackwatch / Barrett & Gots etc. have mislabeled MCS a "fad diagnosis"
and minimized the severity and insulted the victims.

http://www.BreastImplantAwareness.org/QuackWatchWatch.htm


http://thetruthaboutmcs.blogspot.com/2007/08/multiple-chemical-sensitivity-study-of.html
Sunday, August 19, 2007
Multiple chemical sensitivity: study of 52 cases.]

Med Clin (Barc). 2007 Jun 16;129(3):96-9.
[Multiple chemical sensitivity: study of 52 cases.]
[Article in Spanish]

Nogué S, Fernández-Solá J, Rovira E, Montori E,
Fernández-Huerta JM,
Munné P.
Unidades de Toxicología y de Fatiga Crónica. Hospital Clínic.
IDIBAPS.
Universidad de Barcelona. Barcelona. España. SNOGUE@clinic.ub.es.

BACKGROUND AND OBJECTIVE: Multiple chemical sensitivity (MCS) is
characterized by a loss of tolerance to various environmental
chemicals. The objective of this study was to describe patients with
MCS seen in our hospital.
PATIENTS AND METHOD: Patients consecutively seen by the Toxicology and
Chronic Fatigue Units who presented symptoms of MCS were included. The
diagnosis was clinical. All patients completed the Quick Environmental
Exposure and Sensitivity Inventory (QEESI) questionnaire.
RESULTS: Fifty-two patients were included. The average age (standard
deviation) was 47.2 (7.6) years, and 46 (88%) were females. The origin
of the syndrome was related to occupational exposure to various
chemical agents in 31 cases (59.6%), including occupational accidents
in 14 patients (fumigation of the workplace with insecticides). In 20
patients (38.5%), the syndrome could not be associated with any toxic
exposure and was considered a manifestation of chronic fatigue
syndrome. The QEESI showed mean scores of 72.9 (18.6) on the chemical
inhalant intolerance scale, 45.5 (20.6) on the other intolerances
scale, 69.8 (20.6) on the symptom severity scale, 4.4 (1.8) on the
masking index and 66.6 (21.7) on the life impact scale. All patients
were followed up for a minimum of 12 months, and during this period
they remained stable with no deaths.
CONCLUSIONS: MCS normally affects middle-aged women. It is frequently
triggered by exposure to chemical agents, especially insecticides. An
association with chronic fatigue syndrome is common. The prognosis is
good but the patients' quality of life is seriously affected.

PMID: 17594860 [PubMed - in process]

http://www.ncbi.nlm.nih.gov/sites/entrez?db=pubmed&cmd=Retrieve&dopt«stractP
lus&list_uids594860&itool=iconabstr&itool=pubmed_DocSum
Posted by MCS America at 11:06 AM
)

Antworten